CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6110 result(s)

Levetiracetam (pdp-levETIRAcetam)

Last Updated: August 4, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Levetiracetam
Indications: Epilepsy

  • Brand Name: pdp-levETIRAcetam
  • Manufacturer: Pendopharm, a division of Pharmascience Inc.
  • Project Number: SR0653-000
  • Project Status: Received
  • Submission Type: New

voretigene neparvovec (Luxturna)

Last Updated: August 4, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: voretigene neparvovec
Indications: Vision loss, inherited retinal dystrophy

  • Brand Name: Luxturna
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SG0643-000
  • Project Status: Active
  • Submission Type: New

New at CADTH - August 2020

Last Updated: August 5, 2020
Result type: Reports
Product Line: New at CADTH

News and Events Our upcoming webinar on developing a COVID-19 vaccine is taking place on August 12, 2020. Join our panel of experts who will take you inside the race to develop a COVID-19 vaccine. What’s involved in developing a vaccine? And once we have a vaccine, what’s involved in adding it to Canada’s national immunization program? Registra...

etonogestrel (Nexplanon)

Last Updated: July 31, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: etonogestrel
Indications: Prevention of pregnancy

  • Brand Name: Nexplanon
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0648-000
  • Project Status: Active
  • Submission Type: New

Halobetasol propionate and tazarotene (Duobrii)

Last Updated: July 31, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Halobetasol propionate and tazarotene
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Duobrii
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0638-000
  • Project Status: Active
  • Submission Type: New

ustekinumab (Stelara/Stelara I.V)

Last Updated: July 30, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New

icosapent ethyl (Vascepa)

Last Updated: July 30, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: icosapent ethyl
Indications: Ischemic events in statin-treated patients

  • Brand Name: Vascepa
  • Manufacturer: HLS Therapeutics
  • Project Number: SR0619-000
  • Project Status: Active
  • Submission Type: New